SLSN (Solesence Beauty) Market Value to Book Value Ratio

Official company branding of solesence.com (SLSN)

Solesence Inc (SLSN) management is focusing on the implementation of advanced mineral ingredients, effectively protecting margins within the B2B segment. The company's US-based production capacities create unique components demanded by global cosmetic behemoths. The company's price chart demonstrates the asset's dynamics, where the key indicator is 4.31. The brand's positive image as a creator of safe technologies confirms partners' high level of trust in the "clean beauty" concept.

SLSN solesence.com: Market Value to Book Value in the range 04/09/2025 - 10/28/2026

Financial and market metric breakdowns for Solesence Inc (SLSN)

- price and consensus price forecast:
Price Chart solesence.com|SLSN - Broker Consensus Forecast
- market capitalization data:
Market Value Solesence Inc.|SLSN - Full Business Value
- book capitalization data:
Book Value per Share Solesence Inc|SLSN - Accounting Value of Company|Market Capitalization to Book Value Ratio solesence.com|SLSN - Company Total Assets
- debt and liquidity data:
Debt to Equity Solesence Inc|SLSN - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity solesence.com|SLSN - Company Total Debt|Debts to Book Capitalization Solesence Inc.
Initial company analysis:Solesence Beauty - SLSN
Original product of solesence.com

Growing demand for Solesence Inc (SLSN) eco-friendly components from premium brands is reflected in the price-to-book multiplier chart. This indicator compares the company's market value to its net assets, demonstrating a premium for future growth, while an inflated metric signals high share price sensitivity to any operational business disruptions.

Main competitors

Market Value to Book Value Ratio Krystal Biotech, Inc.|APGE (apogeetherapeutics.com) - Capitalization to Book Value Ratio|Market Value to Book Value Ratio Arcutis Biotherapeutics, Inc. ARQT|Market Capitalization to Net Assets Vericel Corp|Oruka Corp (ORKA) - Market Capitalization to Book Value Ratio|Market Value to Book Value sanaramedtech.com (SMTI)|Market Capitalization to Book Value Ratio DBVT (DBV Technologies)|Journey Medical Corp - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Forte Biosciences (FBRX)|EMPG: Market Value to Book Value|SLGL (Sol-Gel) - Market Value to Book Value Ratio|AXIL Brands (AXIL) - Market Cap to Net Assets Ratio|MDCX (Medicus Pharma Ltd.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Market Cap to Net Assets Ratio|Market Value to Book Value BFRI (biofrontera-us.com)|Market Value to Book Value Ratio VYNE|Sonoma Pharmaceuticals Inc. - Market Capitalization to Book Value|Quoin Pharma - Market Value to Book Value Ratio|AZTR - Market Capitalization to Book Value Ratio|Dermata Therapeutics, Inc. - Market Capitalization to Book Value Ratio|ELAB (Elevai Labs Inc) - Market Capitalization to Book Value|Market Value to Book Value Ratio Revance Therapeutics, Inc (RVNC)